A-83-01,
A83-01,
909910-43-6,
A 83-01,
A-83-01,
A83-01,
ALK5 Inhibitor IV,
3-(6-methylpyridin-2-yl)-N-phenyl-4-(quinolin-4-yl)-1H-pyrazole-1-carbothioamide,
TGF-beta inhibitor A-83-01,
1H-Pyrazole-1-carbothioamide,3-(6-methyl-2-pyridinyl)-N-phenyl-4-(4-quinolinyl)-,
J-504722,
C25H19N5S,
Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor IV,
3-(6-Methylpyridin-2-yl)-4-(4-quinolyl)-1-phenylthiocarbamoyl-1H-pyrazole,
TGFss inhibitor A-83-01,
SCHEMBL142081,
CHEMBL1170377,
CTK8E7450,
KS-00001CSC,
AOB1090,
DTXSID60585065,
EX-A482,
SYN5149,
BCP05991,
BS0251,
ZINC13829336,
AKOS024457346,
CS-1437,
RL05717,
3-(6-methyl-2-pyridinyl)-n-phenyl-4-(4-quinolinyl)-1h-pyrazole-1-carbothioamide,
NCGC00165721-01,
NCGC00165721-02,
4CA-0094,
AS-16512,
BC294054,
HY-10432,
QC-11721,
RT-011134,
FT-0746646,
Y1245,
EC-000.2376,
A12358,
W-5384,
3-(6-methylpyridin-2-yl)-N-phenyl-4-quinolin-4-ylpyrazole-1-carbothioamide,
3-(6-methylpyridin-2-yl)-N-phenyl-4-(quinolin-4-yl)-1H-pyrazole-1-carbothio amide,
3-(6-methylpyridin-2-yl)-N-phenyl-4-quinolin-4-yl-1H-pyrazole-1-carbothioamide,
Amthamine dihydrobromide,
cc-656,
HIJMSZGHKQPPJS-UHFFFAOYSA-N,
A3133,
142457-00-9,